12378
1139
9
148
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3521 | γ-Secretase-IN-1 | Compound E | Beta Amyloid , Gamma-secretase |
γ-Secretase-IN-1 is a potent γ-secretase inhibitor that displays partial antiproliferative activity on T-47D cells and inhibits β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage. | |||
T4356 | POL1-IN-1 | Compound 3A | DNA/RNA Synthesis |
POL1-IN-1 (Compound 3A) can effectively inhibit the transcription of RNA polymerase I in the A375 malignant melanoma cell line but has no effect on polymerase II. | |||
T9184L | Compound 3344 hydrochloride | 4-(2,3-dihydro-1,4-benzodioxin-5-yl)-~{N}-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-aniline hydrochloride(2368246-78-8 free base),Compound 3344 hydrochloride (2368246-78-8 free base) | Ras |
Compound 3344 hydrochloride is an inhibitor of KRAS-effector interactions,with an affnity of 126nm. | |||
T8555 | Neuraminidase-IN-1 | Novel NA Inhibitor,Compound Y-1 | Others , Influenza Virus |
Neuraminidase-IN-1 (Compound Y-1) is a novel neuraminidase inhibitor. | |||
T9544 | Compound 1T-0216 | Others | |
Compound 1T-0216 is a blocker of AKT1-FAK interactions and reduces stimulation of FAK phosphorylation by extracellular stress in human SW620 colon cancer cells without affecting basal FAK phosphorylation. | |||
T3586 | Compound 401 | 2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one | DNA-PK |
Compound 401 (2-morpholino-4H-pyrimido[2,1-a]isoquinolin-4-one) is a synthetic DNA-PK inhibitor (IC50 = 0.28 μM) that also targets mTOR but not PI3K. | |||
T9545 | Compound 1T-0219 (SC) | FAK | |
Compound 1T-0219 (SC) is a blocker of AKT1-FAK interaction reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylati... | |||
T13623 | Compound 48/80 trihydrochloride | C48/80 trihydrochloride | Phospholipase |
Compound 48/80 trihydrochloride (C48/80 trihydrochloride) is a mixture of N-methyl-p-methoxyphenethylamine and formaldehyde in a condensation reaction.Compound 48/80 trihydrochloride is a mast cell degranulator and hista... | |||
T35398 | MINA53 inhibitor (Compound 10) | Others | |
MINA53 inhibitor (Compound 10) is an inhibitor of MINA53. | |||
T9853 | STING activator Compound 53 | STING | |
STING activator Compound 53 based on an oxindole core structure demonstrated robust on-target functional activation of STING (human EC50 185 nM) in immortalised and primary cells and a cytokine induction fingerprint cons... | |||
T77771 | Compound 10w | Others | |
Compound 10w, a substituted pyrazolo[1,5-a]pyrimidinamide compound, is a ZSTK474 analog that shows anticancer activity against HeLa cells. | |||
T8745 | PROTAC BRAF-V600E degrader-1 | Compound 23 | Raf |
PROTAC BRAF-V600E degrader-1 (Compound 23) selectively induces degradation of BRAF-V600E but not wildtype BRAF. | |||
T3964 | Glutaminase C-IN-1 | Compound 968,Glutaminase Inhibitor Compound 968 | Glutaminase |
Glutaminase C-IN-1 (Compound 968) is a Glutaminase C allosteric inhibitor. | |||
T11942 | MAP4K4-IN-3 | Compound 17 | MAPK |
MAP4K4-IN-3 (Compound 17) may be a viable target for antidiabetic agents, a serine/threonine protein kinase. | |||
T3587 | NOD-IN-1 | Compound 4 | NOD-like Receptor (NLR) , NOD |
NOD-IN-1 (Compound 4) is a potent mixed inhibitor of nucleotide-binding oligomerization domain (NOD)-like receptors. | |||
T22678 | 3,5-Bis(4-nitrophenoxy)benzoic acid | Compound W | Gamma-secretase |
3,5-Bis(4-nitrophenoxy)benzoic acid (Compound W) is an inhibitor of γ-secretase. It also causes a decrease in the released levels of Aβ42 and notch-1 Aβ-like peptide 25 (Nβ25). | |||
T0274 | Cinoxacin | Compound 64716 | Topoisomerase , Antibacterial , Antibiotic |
Cinoxacin (Compound 64716), an older synthetic antimicrobial, was related to the quinolone class of antibiotics. Its activity was similar to oxolinic acid and nalidixic acid. | |||
T38387 | Compound C108 | GTPase | |
Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma. | |||
T50125 | Compound C749 | ||
Compound C749 is a useful organic compound for research related to life sciences. The catalog number is T50125 and the CAS number is 57-03-4. | |||
T77580 | IK-930 | compound I-32 | YAP |
IK-930 is an orally active TEAD inhibitor (EC50 < 0.1 µM) with potent potency. | |||
T8686 | VUN65671 | Others | |
Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. | |||
T60198 | Compound STK672155 | Others | |
Compound STK672155 can be used for research in the fields of chemistry and life sciences. | |||
TQ0028 | EX229 | Compound 991,C991 | AMPK |
EX229 (C991) is an allosteric activator of AMPK, with Kds of 0.06 μM, 0.06 μM and 0.51 μM for α1β1γ1, α2β1γ1, and α1β2γ1, respectively. | |||
T14119 | ACT-678689 | Compound Example 1.53.4 | Hydroxylase |
ACT-678689 (Compound Example 1.53.4) (Compound Example 1.53.4) is a tryptophan hydroxylase (TPH) inhibitor with an IC50 of 8 nM[1]. | |||
T13114 | CCR2 antagonist 4 | Teijin compound 1 | CCR |
CCR2 antagonist 4 (Teijin compound 1) is a potent and specific antagonist of CCR2(IC50s of 180 nM), and potently inhibits MCP-1-induced chemotaxis(IC50 of 24 nM). | |||
T31004 | Compound 8H | Compound-8H,Compound 8-H,Compound 343 | |
Compound 8H is an inducer of G2/M-phase cell cycle arrest and cell death in cancer cell lines. | |||
T67774 | Compound CDy9 | Carbonic Anhydrase | |
Compound CDy9 is a highly selective inhibitor of carbonic anhydrase (CA) with an IC50 value of 0.18 μM for hCA II. | |||
T10337 | Antimicrobial Compound 1 | Antibacterial | |
Antimicrobial Compound 1 is an alkyl pyridinium compound with Tail 12C, Head 4-carboxyl. Antimicrobial Compound 1 exhibits antimicrobial activities against B. subtilis and E. coli. | |||
T11427 | Antibacterial compound 2 | Antifungal | |
Antibacterial compound 2 is a potent antimicrobial agent effective against many human veterinary pathogens, inhibiting multi-drug resistant staphylococci, enterococci and streptococci, as well as anaerobic bacteria. | |||
T67779 | Compound TPX-0046 | c-RET | |
Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer. | |||
T3971 | CASIN | Pirl1-related Compound 2 | CDK , STAT , Ras |
CASIN (Pirl1-related Compound 2) is a specific inhibitor of GTPase Cdc42 (IC50: 2 uM). | |||
T2503 | PAC-1 | Procaspase activating compound 1 | Apoptosis , Caspase , Autophagy |
PAC-1 (Procaspase activating compound 1) has been used in trials studying the treatment of Lymphoma, Melanoma, Solid Tumors, Breast Cancer, and Thoracic Cancers, among others. | |||
T6146 | Dorsomorphin dihydrochloride | BML-275 2HCl,Compound C dihydrochloride,Dorsomorphin (Compound C) 2HCl,Compound C 2HCl,BML-275 dihydrochloride | AMPK , Autophagy , TGF-beta/Smad |
Dorsomorphin dihydrochloride (BML-275 2HCl) is a potent, selective and ATP-competitive AMPK inhibitor (Ki: 109 nM) and does not exhibit significant activity on structurally related kinases. | |||
T1734 | Rabeprazole Sulfide | Rabeprazole Related Compound E | Proton pump , Antibacterial |
Rabeprazole Sulfide (Rabeprazole Related Compound E) is an antiulcer drug in the class of proton pump inhibitors. | |||
T4170 | PKM2-IN-1 | PKM2 inhibitor,compound 3k | PKM |
PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2. | |||
T13491 | Neuromuscular-targeting compound 1 | Others | |
Neuromuscular-targeting compound 1 can be used to study muscular dystrophy and neuromuscular-related diseases. | |||
T67752 | Compound V007-6018 | Others | |
Compound V007-6018 is a pharmaceutical compound used for drug screening. | |||
T72082 | Compound T72082(SC) | ROS | |
ROS-IN-1 is a mitochondrial ROS inhibitor that can be used to reduce oxidative stress or inhibit reactive oxygen species (ROS) production. | |||
T11035 | DiABZI STING agonist-1 (Tautomerism) | diABZI STING agonist (Compound 3) | STING |
diABZI STING agonist-1 (Tautomerism) (diABZI STING agonist (Compound 3)) is a selective stimulator of interferon genes (STING) receptor agonist, with EC50s of 130, 186 nM for human and mouse, respectively. | |||
TPL0053 | Compound 227105-11-5 | ||
Compound 227105-11-5 is a useful organic compound for research related to life sciences. The catalog number is TPL0053 and the CAS number is 227105-11-5. | |||
T1977 | Dorsomorphin | Compound C,BML-275 | AMPK , Autophagy , TGF-beta/Smad |
Dorsomorphin (BML-275) is an AMPK inhibitor (Ki=109 nM) that is selective and ATP-competitive. Dorsomorphin inhibits the BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin induces autophagy, and possesses antitumor ... | |||
T2028 | NG 52 | NG52,NG-52,Compound 52 | CDK |
NG 52 (NG-52) is a cell-permeable, reversible, and ATP-compatible inhibitor of the cell cycle-regulating kinase Cdc28p and the related Pho85p kinase. | |||
T13572 | Cancer-Targeting Compound 1 | Others | |
Cancer-Targeting Compound 1 can be used in the study of hormone-related cancers, including the treatment or prevention of fibroids, uterine leiomyomas, polycystic ovarian syndrome, or hormone-dependent Cancer, among othe... | |||
T27635 | Isoxepac | Olopatadine USP Related Compound C | Others |
Isoxepac (Olopatadine USP Related Compound C) is a non-steroidal anti-antiphlogistic agent and analgesic. | |||
T0547 | FlutaMide Related CoMpound B | Others | |
FlutaMide Related CoMpound B is used as pharmaceutical intermediates. | |||
T36307 | Compound 28 | ||
Compound 28 (mTOR inhibitor WYE-28) is a selective inhibitor of mTOR (IC50=0.08 nM). Also inhibits PI3Kα (IC50 6 nM). | |||
T0535 | Memantine Related Compound B | 3,5-Dimethyl-1-adamantanol | Others |
Memantine Related Compound B (3,5-Dimethyl-1-adamantanol) is an impurity of Memantine. | |||
T21000 | PiB | Pittsburgh Compound-B,6-OH-BTA-1 | Others |
PiB (Pittsburgh Compound-B) is a standard for analysis of 11C-PiB. 11C-PiB is a β-amyloid PET imaging tracer for Alzheimer's disease diagnosis. | |||
T60122 | Aldometanib | Compound IA-47 (Br- base 2246625-81-8) | Others , AMPK |
Aldometanib (LXY-05-029) is an orally active aldolase inhibitor. Aldometanib prevents FBP from binding to v-ATPase-associated aldolase and activates lysosomal AMPK. Aldometanib can be used for the research of metabolic h... | |||
T41103 | Compound 48/80 | Poly-p-methoxyphenethylmethylamine | |
Compound 48/80, also known as Poly-p-methoxyphenethylmethylamine, is a commonly utilized mast cell activator in animal and tissue models. This compound exerts its effect by stimulating trimeric G-proteins at the mast cel... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN1582 | Compound TN1582(SC) | Antiviral | |
Dihydromollugin is a naphthol ester found in Rubia cordifolia that may have anti-tumour, virus-inhibiting and other activities. | |||
TPL0186 | Compound 1769-24-0 | ||
Compound 1769-24-0 is a natural product for research related to life sciences. The catalog number is TPL0186 and the CAS number is 1769-24-0. | |||
T3811 | Ginsenoside C-K | Ginsenoside compound K,Ginsenoside K | P450 , cell cycle arrest , COX , NO Synthase |
Ginsenoside C-K (Ginsenoside K) is a bacterial metabolite of G-Rb1 exhibiting anti-inflammatory effects by reducing iNOS and COX-2. | |||
T2884 | Cortisone | Kendall's compound E,17-Hydroxy-11-dehydrocorticosterone | Glucocorticoid Receptor , Endogenous Metabolite |
Cortisone (17-Hydroxy-11-dehydrocorticosterone) is a corticosteroid with potent glucocorticoid activity. | |||
TC0036 | Compound Lup-20(29)-en-3-yl acetate | IL Receptor , VEGFR , Others , TNF , COX | |
Lupeol acetate, a derivative of Lupeol, inhibits the progression of rheumatoid arthritis by downregulating TNF-α, IL-1β, MCP-1, COX-2, VEGF and granzyme B. | |||
T0948L | Corticosterone | 17-Deoxycortisol,11β,21-Dihydroxyprogesterone,Kendall's compound B,Corticosterone (From plants) | Glucocorticoid Receptor , Endogenous Metabolite |
Corticosterone (Kendall's compound B) is an adrenocortical steroid with salocorticoid and glucocorticoid activity that is orally active. Corticosterone is involved in the regulation of energy, immune responses, and stres... | |||
TN7210 | Pseudane V | 2-pentylquinolin-4-ol,Compound Z1509149676,2-n-pentyl-4-quinolinol,2-Pentylquinolin-4(1H)-one | Others |
Pseudane V (2-pentylquinolin-4-ol) is a marine derived natural products found in Pseudoalteromonas sp. M2. | |||
T82738 | Chisocheton compound F | ||
Chisocheton compound F, a natural product, can be isolated from the stem bark of Melia toosendan [1]. | |||
T19204 | Compound 2 | Others | |
Compound 2 is used for the research of metabolic bone diseases. | |||
TN6407 | New compound 5 | ||
New compound 5 is a natural product of Schisandra, Schisandraceae. The catalog number is TN6407. New compound 5 can be used as a reference standard. | |||
TN6410 | New compound 3 | ||
New compound 3 can be used for related research in the field of life sciences, and its product number is TN6410. | |||
TN6434 | New compound 4 | ||
New compound 4 is a natural product of Pueraria, Fabaceae. The catalog number is TN6434. New compound 4 can be used as a reference standard. | |||
TN6550 | New compound 2 | ||
New compound 2 is available for research in the life sciences and is product number TN6550. | |||
TN6408 | New compound 6 | ||
New compound 6 is a natural product of Schisandra, Schisandraceae. The catalog number is TN6408. New compound 6 can be used as a reference standard. | |||
T4322 | 2-Hydroxybutyric acid | α-Hydroxybutyric acid | Endogenous Metabolite |
2-Hydroxybutyric acid (α-Hydroxybutyric acid) is a product of protein metabolism and a biomarker for type 2 diabetes and pre-eclampsia. | |||
Fr16664 | Benzothiazolone | 2-Benzothiazolol | |
Compound Fr16664 is a natural product for research related to life sciences. The catalog number is Fr16664 and the CAS number is 934-34-9. | |||
TN1902 | Magnocurarine | Others | |
Magnocurarine is a natural product from Magnolia officinalis. | |||
T3672 | Nomilin | MAPK | |
Nomilin is naturally occurring triterpenoids, have immunomodulatory activity. | |||
T5623 | Bisphenol A | Others , Endogenous Metabolite | |
Bisphenol A is an endogenous metabolic compound of phenols and is widely used in the production of epoxy resins and polycarbonate plastics. It is reproductive, developmental and systemic toxicant and is often classified ... | |||
T7958 | Methyl arachidate | Methyl Icosanoate | Others , Aminopeptidase |
Methyl arachidate (Methyl Icosanoate) is an esterified form of arachidic acid | |||
TN5088 | 2,6-Dimethoxyphenol | Syringol | Others |
2,6-Dimethoxyphenol (Syringol) is a natural product and can be used for the measurement of laccase activity. | |||
T2S0062 | Pulchinenoside B | ||
Compound T2S0062 is a natural product for research related to life sciences. The catalog number is T2S0062 and the CAS number is 135247-95-9. | |||
TWS1977 | Kamebakaurin | Kamebakaurine | NF-κB |
1. Kamebakaurin (Kamebakaurine) has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress. 2. Kamebakaurin inhibits the expression... | |||
Fr16683 | 2,6-Dihydroxyacetophenone | ||
Compound Fr16683 is a natural product for research related to life sciences. The catalog number is Fr16683 and the CAS number is 699-83-2. | |||
Fr14273 | 2'-Aminoacetophenone | ||
Compound Fr14273 is a natural product for research related to life sciences. The catalog number is Fr14273 and the CAS number is 551-93-9. | |||
Fr14500 | 2,3,5-Trimethylpyrazine | ||
Compound Fr14500 is a natural product for research related to life sciences. The catalog number is Fr14500 and the CAS number is 14667-55-1. | |||
T9425 | Epipinoresinol-4'-O-β-D-glucoside | Others | |
Epipinoresinol-4'-O-β-D-glucoside (Simplocosin) is a glucoside compound[1]. | |||
T20504 | Alanylphenylalanine | NSC89630,Ala-phe,H-Ala-Phe-OH,NSC 89630,L-Alanyl-L-phenylalanine,NSC-89630 | Endogenous Metabolite |
Alanylphenylalanine (Ala-phe) is a compound isolated from the brainstem of calves. | |||
TN7228 | 11-oxo-alpha-amyrin | Neoilexonol | |
11-oxo-alpha-amyrin (Neoilexonol) is a triterpene compound extracted from Leonurus japonicus (Lamiaceae) and is a natural compound . | |||
TN1089 | Hydroxy-β-sanshool | Hydroxy-beta-sanshool | Others |
Hydroxy-β-sanshool is a pungent compound obtained from Zanthoxylum piperitum. | |||
T6S0535 | Pinoresinol diglucoside | Pinoresinol Diglucopyranoside | Glucosidase |
1. Pinoresinol diglucoside (Pinoresinol Diglucopyranoside) is a putative α-glucosidase inhibiting compound. 2. Pinoresinol diglucoside is a important antihypertensive compound. | |||
T3854 | Camelliaside A | Others | |
Camelliaside A is a compound with the anti-inflammatory effect. | |||
TN6767 | ACETOXYVALERENIC ACID | Others | |
Acetoxyvalerenic acid is a natural compound isolated from valerian. | |||
TN7061 | Yuanamide | Others | |
Yuanamide is a natural compound that belongs to the class of alkaloids. | |||
T5S2350 | Beta-Acetoxyisovalerylshikonin | Acetoxyisovalerylalkannin | Others |
Acetoxyisovalerylshikonin, a naphthoquinone derivative extracted from Arnebia euchroma, is a chemical compound. | |||
TWO2724 | N,N-Bis(2-hydroxyethyl)-p-phenylenediami | Others | |
N,N-Bis(2-hydroxyethyl)-p-phenylenediamine is an intermediate compound. | |||
TN7230 | Butyl chlorogenate | Others | |
Butylchlorogenate is a natural compound isolated from Lonicera japonica, Urceola rosea. | |||
T2991 | 3,3'-Diindolylmethane | HB 236,DIM,Arundine | Androgen Receptor , Autophagy |
3,3'-Diindolylmethane (DIM), a small molecule compound, is a proposed Y preventive agent. | |||
T8228 | Ethyl chrysanthemate | Ethyl chrysanthemumate | Others |
Ethyl chrysanthemate (Ethyl chrysanthemumate) is an allelochemical compound used as an attractant | |||
T4961 | 9''-Methyl salvianolate B | 9'-Methyl lithospermate B | Others |
9'-Methyl lithospermate B is a phenolic compound extracted from Radix Salvia miltiorrhizae. | |||
T21104 | 4-Decanol | AI3-19949,Decan-4-ol | |
4-Decanol (Decan-4-ol) is a compound isolated from the roots of Valeriana jatamansi Jones and Epilobium angustifolium L. It may have anti-inflammatory and 4-Decanol is a compound isolated from the roots of Valeriana jata... | |||
T8174 | Saikosaponin F | Others | |
Saikosaponin F is a natural compound found in Bupleurum (B.) falcatum L. | |||
T13903 | Stearoylethanolamide | N-(2-Hydroxyethyl)octadecanamide | Apoptosis |
Stearoylethanolamide(N-(2-Hydroxyethyl)octadecanamide) is a cannabinoid compound present in the brains of humans, rats, and mice with pro-apoptotic activity. | |||
T21130 | Precocene II | AI3-36847,Ageratochromene,BRN 0160683 | Others |
Precocene II (Ageratochromene), an antiallotropin compound, inhibits juvenile hormone biosynthesis. Precocene II has insecticidal, antifungal, antibacterial, and antioxidant activities. | |||
T0986 | Flucytosine | 5-Fluorocytosine,Ro 2-9915,Fluorocytosine,NSC 103805 | DNA/RNA Synthesis , Antibiotic , Antifungal |
Flucytosine (NSC 103805) is a pyrimidine compound and a fluorinated cytosine analog exhibiting antifungal activity. | |||
T19262 | D-Glucose 6-phosphate disodium salt | D-Glucose 6-phosphate disodium salt | Endogenous Metabolite |
D-Glucose 6-phosphate disodium salt is a compound widely present in biological systems. It is a molecule formed when glucose undergoes phosphorylation at the 6th carbon. This compound participates in various metabolic re... | |||
T8159 | Senkyunolide H | Others | |
Senkyunolide H is a natural compound found in Ligusticum chuanxiong Hort. | |||
T8015 | 4-METHOXYCHALCONE | 2-(4-Methoxybenzal)Acetophenone | Others |
4-METHOXYCHALCONE (2-(4-Methoxybenzal)Acetophenone) is a natural compound that enhanced adipocyte differentiation, | |||
T8023 | 2,3,4-Trihydroxybenzoic acid | Others | |
2,3,4-Trihydroxybenzoic acid is natural compound,with antioxidant activity | |||
TN2704 | 2,3-Dihydroxy-4-methoxybenzoic acid | Others | |
2,3-Dihydroxy-4-methoxybenzoic acid is a compound isolated from sweet cherry fruit. | |||
------------------------ More ------------------------ |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-01041 | Compound TMPY-01041 | ||
TMPY-00876 | Legumain Protein, Mouse, Recombinant (His) | Mouse | HEK293 |
The Mammalian Legumain, also known as LGMN, also called asparaginyl endopeptidase (AEP), is a cysteine protease belonging to peptidase family C13 with strict specificity for hydrolysis of asparaginyl bonds. Known previou... | |||
TMPY-01356 | S100A8 Protein, Human, Recombinant (His) | Human | Baculovirus-Insect Cells |
S100A8 is a member of the S100 protein family containing 2EF-hand calcium-binding motifs. S100 proteins are involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation.... | |||
TMPY-03509 | TCTP/TPT1 Protein, Human, Recombinant (His) | Human | E. coli |
Tumor protein, also known as TPT1, is a highly conserved protein among many eukaryotic organisms. Tumor protein is involved in a variety of cellular activities, including microtubule stabilization, calcium-binding activi... | |||
TMPY-02787 | Aconitase 2 Protein, Mouse, Recombinant (His & GST) | Mouse | Baculovirus-Insect Cells |
A homozygous missense mutation was identified in the ACO2 gene (c.1240T>G p.Phe414Val) that segregated with HSP complicated by intellectual disability and microcephaly. Lymphoblastoid cell lines of homozygous carrier pat... | |||
TMPY-02545 | Aconitase 2 Protein, Human, Recombinant (His & GST) | Human | Baculovirus-Insect Cells |
A homozygous missense mutation was identified in the ACO2 gene (c.1240T>G p.Phe414Val) that segregated with HSP complicated by intellectual disability and microcephaly. Lymphoblastoid cell lines of homozygous carrier pat... | |||
TMPY-02873 | Legumain Protein, Sus scrofa (Pig), Recombinant (His) | Sus scrofa (Pig) | HEK293 |
The Mammalian Legumain, also known as LGMN, also called asparaginyl endopeptidase (AEP), is a cysteine protease belonging to peptidase family C13 with strict specificity for hydrolysis of asparaginyl bonds. Known previou... | |||
TMPY-06640 | Legumain Protein, Human, Recombinant (His) | Human | HEK293 |
The Mammalian Legumain, also known as LGMN, also called asparaginyl endopeptidase (AEP), is a cysteine protease belonging to peptidase family C13 with strict specificity for hydrolysis of asparaginyl bonds. Known previou... | |||
TMPY-03556 | S100A8 Protein, Mouse, Recombinant (His) | Mouse | E. coli |
S100A8 is a member of the S100 protein family containing 2EF-hand calcium-binding motifs. S100 proteins are involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation.... |
Cat No. | Product Name | ||
---|---|---|---|
L3410 | Preclinical Compound Library | 709 compounds | |
A unique collection of 709 preclinical compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L3400 | Clinical Compound Library | 3480 compounds | |
A unique collection of 3480 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS); | |||
L8110 | Reprogramming Compound Library | 1840 compounds | |
A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L2910 | Antioxidant Compound Library | 1330 compounds | |
Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ... | |||
L1500 | GPCR Compound Library | 1940 compounds | |
A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
L8400 | Hematonosis Compound Library | 524 compounds | |
A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
L4000 | Bioactive Compound Library | 14590 compounds | |
A collection of 14590 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification; | |||
L4900 | Cardiotoxicity Compound Library | 132 compounds | |
A unique collection of 132 cardiotoxicity inducing compounds for toxicological study; | |||
L8710 | Cuproptosis Compound Library | 411 compounds | |
TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
L3200 | Autophagy Compound Library | 1248 compounds | |
A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L1200 | Epigenetics Compound Library | 960 compounds | |
Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L8600 | Ubiquitination Compound Library | 214 compounds | |
A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening; | |||
L7900 | Osteogenesis Compound Library | 320 compounds | |
A unique collection of 320 osteogenesis related compounds for high throughput and high content screening; | |||
L8700 | Ferroptosis Compound Library | 800 compounds | |
A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study; | |||
L5500 | Toxic Compound Library | 277 compounds | |
A unique collection of 277 toxic substances for high throughput screening (HTS) and high content screening (HCS); | |||
L9420 | Exosome Compound Library | 80 compounds | |
80 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
L9300 | Macrocyclic Compound Library | 216 compounds | |
216 macrocyclic compounds of known activity for high-throughput, high-content screening; | |||
L3510 | Methylation Compound Library | 131 compounds | |
131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
L1720 | Nucleotide Compound Library | 337 compounds | |
A unique collection of 337 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs; | |||
L9000 | Apoptosis Compound Library | 1796 compounds | |
A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
L2520 | Glycometabolism Compound Library | 708 compounds | |
708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
L9600 | Peptide Compound Library | 800 compounds | |
800 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
L5900 | CNS-Penetrant Compound Library | 516 compounds | |
A unique collection of 516 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L4510 | Anti-Parasitic Compound Library | 420 compounds | |
420 well-chosen unique anti-parasitic small molecules; | |||
L1700 | Anti-Viral Compound Library | 1040 compounds | |
A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
L7100 | Anti-Obesity Compound Library | 2286 compounds | |
A unique collection of 2286 anti-obesity compounds for high throughput and high content screening; | |||
L2170 | Immuno-Oncology Compound Library | 454 compounds | |
A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening; | |||
L1900 | Anti-Diabetic Compound Library | 690 compounds | |
A unique collection of 690 diabetes related compounds; | |||
L9810 | Anti-Fibrosis Compound Library | 1180 compounds | |
A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS; | |||
L1120 | AMPK-Targeted Compound Library | 80 compounds | |
80 well-chosen unique AMPK-targeted small molecules; | |||
L3700 | JAK-STAT Compound Library | 256 compounds | |
A unique collection of 256 JAK/STAT signaling targeted compounds for high throughput and high content screening; | |||
L1110 | Microtubule-Targeted Compound Library | 155 compounds | |
A unique collection of 155 microtubule-targeted compounds can be used in HTS and HCS; | |||
L5300 | Mitochondria-Targeted Compound Library | 830 compounds | |
A unique collection of 830 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine; | |||
L7110 | Anti-Hypertension Compound Library | 719 compounds | |
719 hypertension-related small molecules for high-throughput and high-content screening. | |||
L2900 | Oxidation-Reduction Compound Library | 1279 compounds | |
1279 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening. | |||
L1800 | Anti-Infection Compound Library | 2977 compounds | |
A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
L4500 | Anti-Fungal Compound Library | 253 compounds | |
A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
L4520 | Anti-Bacterial Compound Library | 921 compounds | |
A unique collection of 921 antibacterial bioactive compounds, a powerful tool for antibacterial drug development; | |||
L9820 | Beta-Lactam Compound Library | 105 compounds | |
A unique collection of 105 beta-lactam compounds, can be used in HTS and HCS; | |||
L8200 | Anti-Aging Compound Library | 3324 compounds | |
A unique collection of 3324 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2100 | Anti-Cancer Compound Library | 7360 compounds | |
A unique collection of 7360 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L4020 | NO PAINS Compound Library | 9555 compounds | |
TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9555 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea... | |||
L1580 | GPCR Compound Library Plus | 338 compounds | |
Well-chosen 338 GPCR targeting compounds with unique structures; | |||
L4800 | Angiogenesis related Compound Library | 1370 compounds | |
A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
L6210 | Tibetan medicine Compound Library | 754 compounds | |
A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
L4700 | Immunology/Inflammation Compound Library | 4720 compounds | |
A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
L3500 | Histone Modification Compound Library | 480 compounds | |
A unique collection of 480 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2530 | Mouse Metabolite Compound Library | 224 compounds | |
A unique collection of 224 mouse metabolites, which can be used for HTS and HCS; | |||
L9200 | Drug Repurposing Compound Library | 4630 compounds | |
A unique collection of 4630 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L3100 | Hematopoietic Toxicity Compound Library | 104 compounds | |
A unique collection of 104 compounds with defined hematopoietic toxicity for high throughput and high content drug screening; | |||
L7000 | Bioactive Lipid Compound Library | 385 compounds | |
A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ... | |||
L8100 | Cell Cycle Compound Library | 695 compounds | |
A unique collection of 695 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L8300 | Chromatin Modification Compound Library | 256 compounds | |
A unique collection of 256 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS); | |||
L7700 | Neural Regeneration Compound Library | 529 compounds | |
A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
L2600 | Neuronal Signaling Compound Library | 2540 compounds | |
A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L2510 | Lipid Metabolism Compound Library | 496 compounds | |
A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
L2610 | Neurotransmitter Receptor Compound Library | 1513 compounds | |
A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening; | |||
L2550 | Glutamine Metabolism Compound Library | 580 compounds | |
A unique collection of 580 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ... | |||
L4710 | Nonsteroidal Anti-Inflammatory Compound Library | 530 compounds | |
530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
L2620 | Anti-Neurodegenerative Disease Compound Library | 2150 compounds | |
A unique collection of 2150 compounds related to neurodegenerative diseases can be used for HTS or HCS; | |||
L2191 | Anti-Breast Cancer Compound Library | 1965 compounds | |
A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study; | |||
L3800 | NF-κB Signaling Compound Library | 740 compounds | |
A unique collection of 740 compounds targeting NF-κB signaling for high throughput screening and high content screening; | |||
L2190 | Anti-Lung Cancer Compound Library | 1735 compounds | |
A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study; | |||
L5200 | Anti-Metabolism Disease Compound Library | 1558 compounds | |
A unique collection of 1558 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1710 | Anti-COVID-19 Compound Library | 1160 compounds | |
A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | |||
L1380 | Transcription Factor-Targeted Compound Library | 704 compounds | |
Well-chosen 704 compounds with unique structures targeting transcription factor; | |||
L2160 | Anti-Cancer Active Compound Library | 3250 compounds | |
A unique collection of 3250 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L9830 | Anti-Parkinson's Disease Compound Library | 908 compounds | |
A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
L5400 | Anti-Cardiovascular Disease Compound Library | 1428 compounds | |
A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2700 | Adrenergic Receptor-Targeted Compound Library | 219 compounds | |
A unique collection of 219 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification; | |||
L2120 | Anti-Cancer Clinical Compound Library | 2614 compounds | |
A unique collection of 2614 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L2192 | Anti-Pancreatic Cancer Compound Library | 2267 compounds | |
A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
L2130 | Anti-Cancer Metabolism Compound Library | 1280 compounds | |
A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
L4100 | TGF-beta/Smad Compound Library | 185 compounds | |
A unique collection of 185 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening; | |||
L4600 | Selected Plant-Sourced Compound Library | 3076 compounds | |
A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
L9840 | Anti-Alzheimer's Disease Compound Library | 1040 compounds | |
A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
L1300 | PI3K-AKT-mTOR Compound Library | 425 compounds | |
A unique collection of 425 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling; | |||
L4150 | Featured Novel Bioactive Compound Library | 990 compounds | |
It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis... | |||
L2140 | Cancer Cell Differentiation Compound Library | 413 compounds | |
A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
L9700 | Endoplasmic Reticulum Stress Compound Library | 193 compounds | |
A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
L4300 | Wnt/Hedgehog/Notch Compound Library | 240 compounds | |
A unique collection of 240 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening; | |||
L2800 | Serotonin Receptor-Targeted Compound Library | 275 compounds | |
A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
L3900 | DNA Damage & Repair Compound Library | 937 compounds | |
A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L1310 | Cytoskeletal Signaling Pathway Compound Library | 773 compounds | |
A unique collection of 773 cytoskeleton-related compounds, can be used for HTS and HCS; | |||
L6300 | Food as Medicine Compound Library | 1302 compounds | |
A unique collection of 1302 compounds from food as medicine for high throughput and high content screening; | |||
L8000 | Stem Cell Differentiation Compound Library | 1213 compounds | |
A unique collection of 1213 stem cell differentiation signaling targeted compounds for high throughput and high content screening; | |||
L7500 | Coagulation and Anticoagulation Compound Library | 154 compounds | |
A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L8500 | HIF-1 Signaling Pathway Compound Library | 1352 compounds | |
A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies; | |||
L6710 | Anti-Inflammatory Traditional Chinese Medicine Compound Library | 1260 compounds | |
A collection of 1260 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study; | |||
L5510 | Drug-induced Liver Injury (DILI) Compound Library | 1040 compounds | |
A unique collection of 1040 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening; | |||
L3980 | DNA Damage and Repair Compound Library Plus | 667 compounds | |
Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
L6720 | Anti-COVID-19 Traditional Chinese Medicine Compound Library | 1162 compounds | |
A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | |||
L2521 | Glycolysis Compound Library | 560 compounds | |
560 glycolysis-related active compounds for high-throughput and high-content screening. | |||
L9860 | Antidepressant Compound Library | 1181 compounds | |
1181 compounds associated with depression that can be used for high-throughput and high-content screening | |||
L2560 | Metabolism Compound Library | 2350 compounds | |
A unique collection of 2350 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
L8720 | Pyroptosis Compound Library | 1077 compounds | |
1077 types of active small molecules associated with pyroptosis for high-throughput and high-content screening. | |||
L1510 | Nuclear Receptor Compound Library | 546 compounds | |
A unique collection of 546 nuclear receptor signaling targeted compounds for high throughput and high content screening; | |||
L6230 | Miao medicine Compound Library | 540 compounds | |
A unique collection of 540 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening. | |||
L2400 | Endocrinology-Hormone Compound Library | 813 compounds | |
A unique collection of 813 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L7200 | Calcium Channel Compound Library | 143 compounds | |
A unique collection of 143 calcium channel blockers and agonists for high throughput and high content screening; | |||
L9850 | Orally Active Compound Library | 2484 compounds | |
A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
L2630 | Neuronal Differentiation Compound Library | 680 compounds | |
680 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease. | |||
L2180 | Anti-Cancer Compound Library Plus | 1468 compounds | |
Well-chosen 1468 anti-tumor compounds with unique structures; | |||
L2193 | Anti-Liver Cancer Compound Library | 1816 compounds | |
1816 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies. | |||
DF4600 | Drug-like natural compound library | 522 compounds | |
L1520 | Membrane Protein-targeted Compound Library | 4240 compounds | |
L6220 | Traditional Mongolian Medicine Compound Library | 960 compounds | |
A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
L2195 | Anti-Prostate Cancer Compound Library | 2096 compounds | |
2096 compounds associated with prostate cancer that can be used for high-throughput and high-content screening. | |||
L2194 | Anti-Colorectal Cancer Compound Library | 1565 compounds | |
1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
L2196 | Anti-Ovarian Cancer Compound Library | 1888 compounds | |
A unique collection of 1888 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study; | |||
L2501 | Human Endogenous Metabolite Compound Library Plus | 1300 compounds | |
A unique collection of 1300 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening. | |||
L6750 | PBCRBS Traditional Chinese Medicine Compound Library | 588 compounds | |
A unique collection of 588 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis. | |||
L3300 | Histamine & Melatonin Receptor-Targeted Compound Library | 155 compounds | |
A unique collection of 155 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
L6740 | Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library | 386 compounds | |
A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
L6900 | Rare Natural Product Library | 180 compounds | |
A unique collection of 180 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS); | |||
L6120 | Flavonoid Natural Product Library | 477 compounds | |
A unique collection of 477 flavonoids can be used for high throughput and high content screening; | |||
L6400 | Marine Natural Product Library | 148 compounds | |
A unique collection of 148 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L6620 | Antiparasitic Natural Product Library | 253 compounds | |
A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS); | |||
L6010 | Natural Product Library | 3720 compounds | |
A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
L6610 | Anti-infective Natural Product Library | 1070 compounds | |
A unique collection of 1070 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS); | |||
L6150 | Covalent Natural Product Library | 596 compounds | |
Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening. | |||
L6020 | Selectable Natural Product Library | 16627 compounds | |
A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species; | |||
L6500 | Microbial Natural Product Library | 560 compounds | |
A unique collection of 560 microbial natural products for high throughput screening (HTS) and high content screening (HCS); | |||
NY1000 | Natural Product Derivatives Library | 4000 compounds | |
The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
L6001 | Mini Fungal Metabolite Natural Product Screening Library | Inquiry | |
L6100 | Polyphenolic Natural Product Library | 640 compounds | |
A unique collection of 640 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS); | |||
L6130 | Terpene Natural Product Library | 522 compounds | |
A unique collection of 522 natural terpenes and terpenoids can be used for high throughput and high content screening; | |||
L6110 | Alkaloid Natural Product Library | 468 compounds | |
A unique collection of 468 natural alkaloids can be used for high throughput and high content screening; | |||
L6000 | Natural Product Library for HTS | 4320 compounds | |
A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can... | |||
L6800 | Chinese Pharmacopoeia Natural Product Library | 2070 compounds | |
A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
L6140 | Saccharide and Glycoside Natural Product Library | 364 compounds | |
A unique collection of 364 saccharides and glycosides compounds can be used for HTS and HCS; | |||
L6030 | Natural Product Derivatives Library for CADD | 163000 compounds | |
Large quantity: contains 163,000 natural product derivatives and the number is continuously updating; | |||
L6700 | Anti-Tumor Natural Product Library | 1800 compounds | |
A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
L6600 | Anti-Gastroenteritis Natural Product Library | 223 compounds | |
A unique collection of 223 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS); | |||
L6160 | RO5 Drug-like Natural Product Library | 2743 compounds | |
A unique collection of 2743 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening; | |||
L4010 | Bioactive Compounds Library Max | 22706 compounds | |
A collection of 22706 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
L1000 | Approved Drug Library | 2863 compounds | |
A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L7820 | High Solubility Micro Fragment Library | 1082 compounds | |
The compound library of highly soluble micro-fragments consists of 1082 low-molecular-weight fragments. | |||
L9100 | Phosphatase Inhibitor Library | 80 compounds | |
A collection of 80 phosphatase inhibitors with known activity; | |||
L5600 | Mini Scaffold Library | 5000 compounds | |
Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds; | |||
L9411 | Cysteine Covalent Library | 72 compounds | |
The cysteine covalent library contains 72 compounds. | |||
L7850 | High Solubility 3D Diversity Fragment Library | 1081 compounds | |
The library of highly soluble 3D structural diversity fragments contains 1081 compounds. | |||
L4200 | FDA-Approved Drug Library | 1729 compounds | |
A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
LF1000 | Pre-plated Diversity Sets | 50000 compounds | |
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 compounds with no structure overlap. | |||
L6200 | The Yao nationality medicine Library | 225 compounds | |
A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
L9500 | Target-Focused Phenotypic Screening Library | 1832 compounds | |
A unique collection of 1832 annotated bioactive compounds with clear targets, suitable for phenotypic screening; | |||
L1010 | FDA-Approved & Pharmacopeia Drug Library | 3158 compounds | |
3158 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS); | |||
L9410 | Covalent Inhibitor Library | 1949 compounds | |
A unique collection of 1949 covalent Inhibitors and other molecules with common warheads like chloroacetyl,2-Chloropropionyl,Acryloyl,sulfonyl fluoride, alkyne,acrylamide, ketocarbonyl,disulfide bond, etc. |